Get the Stockscreener App
0.3638
2.52%
-0.0094
Renovaro Inc stock is traded at $0.3638, with a volume of 631.46K.
It is down -2.52% in the last 24 hours and down -37.15% over the past month.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
See More
Previous Close:
$0.3732
Open:
$0.38
24h Volume:
631.46K
Relative Volume:
0.53
Market Cap:
$65.23M
Revenue:
-
Net Income/Loss:
$-41.23M
P/E Ratio:
-0.5197
EPS:
-0.7
Net Cash Flow:
$-11.54M
1W Performance:
-9.43%
1M Performance:
-37.15%
6M Performance:
-31.74%
1Y Performance:
-76.22%
1-Day Range:
$0.35
$0.384
1-Week Range:
$0.3412
$0.4479
52-Week Range:
$0.3214
$2.34
Renovaro Inc Stock (RENB) Company Profile
Name
Renovaro Inc
Sector
Industry
Phone
45 39179840
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare RENB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.3638 | 65.23M | 0 | -41.23M | -11.54M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.49 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.86 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.97 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
254.85 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.46 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovaro Inc Stock (RENB) Latest News
Market Watch: Renovaro Inc (RENB)’s Noteworthy Gain, Closing at 0.37 - DWinneX
Investor’s Delight: Renovaro Inc (RENB) Closes Weak at 0.39, Down -16.49 - DWinneX
AI medicine company Renovaro to use Nebul's AI cloud infrastructure - Data Center Dynamics
Renovaro Inc [RENB] stock for 1,448 USD was sold by William Anderson Wittekind - knoxdaily.com
RENB’s 52-Week Rollercoaster: From $0.32 to $2.34 – What’s Next for Investors? - investchronicle.com
Renovaro BioSciences expands collaboration with Nebul - MSN
Insider’s View: Deciphering Renovaro Inc (RENB)’s Financial Health Through Ratios - DWinneX
Renovaro Inc (RENB)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Renovaro Expands Partnership With Nebul To Accelerate AI-Driven Cancer Diagnostics - Nasdaq
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs | RENB Stock News - GuruFocus
Renovaro (ticker) and Nebul Enhance Partnership to Boost Diagnostic Innovations | RENB Stock News - GuruFocus
Renovaro Inc. Expands Collaboration with Nebul to Enhance Early Cancer Detection Through Advanced AI Technology - Nasdaq
Renovaro Secures High-Powered Computing from Nebul Through - GlobeNewswire
Renovaro's New AI Partnership Targets Breakthrough in Early-Stage Lung Cancer Detection Technology - Stock Titan
Renovaro Inc (NASDAQ: RENB) Has Great Upside Potential - Stocksregister
Renovaro faces Nasdaq delisting over share price issue By Investing.com - Investing.com Canada
Renovaro faces Nasdaq delisting over share price issue - Investing.com
Renovaro Inc. (NASDAQ:RENB) Shares Purchased by Corebridge Financial Inc. - Defense World
Renovaro closes merger transaction with BioSymetrics - Pharmaceutical Business review -
Renovaro merges with BioSymetrics to boost AI drug discovery - Investing.com
Renovaro merges with BioSymetrics to boost AI drug discovery By Investing.com - Investing.com South Africa
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven B - GuruFocus
Walmart stands by its annual financial outlook but pulls back its 1Q view amid tariff uncertainty - The Globe and Mail
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewswire
Major AI Breakthrough: Renovaro-BioSymetrics Merger Creates Powerhouse in Precision Medicine - Stock Titan
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and ... - Bluefield Daily Telegraph
Morgan Stanley (MS) Is About to Report Q1 Earnings This Week. Here’s What to Expect - The Globe and Mail
CPKC to report first-quarter 2025 earnings results on April 30 - The Globe and Mail
3 Reasons FDP is Risky and 1 Stock to Buy Instead - The Globe and Mail
2 Reasons to Like AMZN and 1 to Stay Skeptical - The Globe and Mail
Predictive Oncology Ends Merger Talks with Renovaro - TipRanks
RENB: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
Renovaro says Predictive Oncology terminates merger transaction - MSN
RENB stock touches 52-week low at $0.4 amid sharp annual decline - Investing.com Canada
Renovaro Biosciences faces merger setback with Predictive Oncology - Investing.com India
Sector Update: Health Care - marketscreener.com
Health Care Stocks Tumble On Multiple Fronts - Finimize
Renovaro Says Predictive Oncology Terminates Merger Transaction With Co - marketscreener.com
RENB stock touches 52-week low at $0.4 amid sharp annual decline By Investing.com - Investing.com South Africa
Renovaro Biosciences faces merger setback with Predictive Oncology By Investing.com - Investing.com South Africa
Renovaro BioSciences (RENB) Challenges Merger Termination - GuruFocus
Renovaro Biosciences Announces Breach Of Agreement By Predictive Oncology, Legal Action Pending - Nasdaq
Renovaro Says Predictive Oncology Terminates Merger Deal; Shares Fall - MarketScreener
Renovaro Provides Update to Definitive Agreement with Predictive Oncology - GlobeNewswire
3 Quantum Computing Stocks to Buy Now, According to Analysts – 4/2/2025 - The Globe and Mail
Charles Schwab Investment Management Inc. Buys 163,160 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Predictive Oncology pushing forward with Renovaro merger despite $10.8M loss in 2024 - The Business Journals
Predictive Oncology Advances AI Merger Plans Despite $10.8M Loss: Key Strategic Moves Revealed - Stock Titan
Bank of New York Mellon Corp Grows Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
Renovaro Inc Stock (RENB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):